nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Flutamide—prostate cancer	0.124	0.347	CbGbCtD
Triamterene—CYP1A2—Estrone—prostate cancer	0.0894	0.251	CbGbCtD
Triamterene—CYP1A2—Conjugated Estrogens—prostate cancer	0.0585	0.164	CbGbCtD
Triamterene—CYP1A2—Estradiol—prostate cancer	0.0514	0.144	CbGbCtD
Triamterene—CYP1A2—Etoposide—prostate cancer	0.0335	0.0941	CbGbCtD
Triamterene—SCNN1G—prostate gland—prostate cancer	0.0192	0.0794	CbGeAlD
Triamterene—SCNN1D—prostate gland—prostate cancer	0.0192	0.0794	CbGeAlD
Triamterene—SCNN1G—seminal vesicle—prostate cancer	0.0162	0.0672	CbGeAlD
Triamterene—SCNN1B—prostate gland—prostate cancer	0.0162	0.0671	CbGeAlD
Triamterene—SCNN1A—prostate gland—prostate cancer	0.015	0.062	CbGeAlD
Triamterene—SCNN1D—epithelium—prostate cancer	0.0141	0.0584	CbGeAlD
Triamterene—SCNN1G—renal system—prostate cancer	0.0131	0.0541	CbGeAlD
Triamterene—SCNN1G—urethra—prostate cancer	0.0129	0.0532	CbGeAlD
Triamterene—SCNN1B—epithelium—prostate cancer	0.0119	0.0493	CbGeAlD
Triamterene—SCNN1B—renal system—prostate cancer	0.0111	0.0457	CbGeAlD
Triamterene—SCNN1A—epithelium—prostate cancer	0.011	0.0456	CbGeAlD
Triamterene—SCNN1B—urethra—prostate cancer	0.0109	0.0449	CbGeAlD
Triamterene—SCNN1A—renal system—prostate cancer	0.0102	0.0423	CbGeAlD
Triamterene—SCNN1A—urethra—prostate cancer	0.01	0.0415	CbGeAlD
Triamterene—CYP1A2—urine—prostate cancer	0.01	0.0415	CbGeAlD
Triamterene—SCNN1D—testis—prostate cancer	0.00846	0.035	CbGeAlD
Triamterene—SCNN1B—testis—prostate cancer	0.00715	0.0296	CbGeAlD
Triamterene—SCNN1A—testis—prostate cancer	0.0066	0.0273	CbGeAlD
Triamterene—SCNN1D—lymph node—prostate cancer	0.00613	0.0254	CbGeAlD
Triamterene—SCNN1B—lymph node—prostate cancer	0.00518	0.0214	CbGeAlD
Triamterene—SCNN1A—lymph node—prostate cancer	0.00479	0.0198	CbGeAlD
Triamterene—Jaundice—Flutamide—prostate cancer	0.00311	0.0118	CcSEcCtD
Triamterene—Blood urea increased—Conjugated Estrogens—prostate cancer	0.00269	0.0102	CcSEcCtD
Triamterene—CYP1A2—renal system—prostate cancer	0.00245	0.0101	CbGeAlD
Triamterene—Thrombocytopenia—Estramustine—prostate cancer	0.00225	0.00858	CcSEcCtD
Triamterene—Jaundice—Bicalutamide—prostate cancer	0.00225	0.00858	CcSEcCtD
Triamterene—Renal failure acute—Conjugated Estrogens—prostate cancer	0.00224	0.00853	CcSEcCtD
Triamterene—Anaphylactic shock—Estrone—prostate cancer	0.0022	0.00838	CcSEcCtD
Triamterene—Hyperkalaemia—Mitoxantrone—prostate cancer	0.00209	0.00795	CcSEcCtD
Triamterene—Dry mouth—Nilutamide—prostate cancer	0.00208	0.00794	CcSEcCtD
Triamterene—Blood urea increased—Mitoxantrone—prostate cancer	0.00201	0.00764	CcSEcCtD
Triamterene—Thrombocytopenia—Flutamide—prostate cancer	0.00199	0.00758	CcSEcCtD
Triamterene—Fatigue—Abiraterone—prostate cancer	0.00193	0.00734	CcSEcCtD
Triamterene—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00192	0.00731	CcSEcCtD
Triamterene—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.00188	0.00717	CcSEcCtD
Triamterene—Dry mouth—Degarelix—prostate cancer	0.00186	0.00709	CcSEcCtD
Triamterene—Anaphylactic shock—Degarelix—prostate cancer	0.00182	0.00695	CcSEcCtD
Triamterene—Dry mouth—Cabazitaxel—prostate cancer	0.00175	0.00668	CcSEcCtD
Triamterene—Fatigue—Flutamide—prostate cancer	0.00175	0.00668	CcSEcCtD
Triamterene—Thrombocytopenia—Cabazitaxel—prostate cancer	0.00168	0.00641	CcSEcCtD
Triamterene—Renal failure acute—Mitoxantrone—prostate cancer	0.00167	0.00636	CcSEcCtD
Triamterene—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00165	0.0063	CcSEcCtD
Triamterene—Photosensitivity reaction—Goserelin—prostate cancer	0.00165	0.00627	CcSEcCtD
Triamterene—Asthenia—Abiraterone—prostate cancer	0.0016	0.00611	CcSEcCtD
Triamterene—Diarrhoea—Estramustine—prostate cancer	0.00158	0.006	CcSEcCtD
Triamterene—Fatigue—Degarelix—prostate cancer	0.00157	0.00599	CcSEcCtD
Triamterene—Jaundice—Goserelin—prostate cancer	0.00157	0.00597	CcSEcCtD
Triamterene—Diarrhoea—Abiraterone—prostate cancer	0.00153	0.00583	CcSEcCtD
Triamterene—Dry mouth—Bicalutamide—prostate cancer	0.0015	0.00573	CcSEcCtD
Triamterene—Fatigue—Cabazitaxel—prostate cancer	0.00148	0.00564	CcSEcCtD
Triamterene—Asthenia—Nilutamide—prostate cancer	0.00147	0.00558	CcSEcCtD
Triamterene—Vomiting—Estramustine—prostate cancer	0.00146	0.00557	CcSEcCtD
Triamterene—Asthenia—Flutamide—prostate cancer	0.00146	0.00556	CcSEcCtD
Triamterene—Dizziness—Estrone—prostate cancer	0.00145	0.00554	CcSEcCtD
Triamterene—Rash—Estramustine—prostate cancer	0.00145	0.00553	CcSEcCtD
Triamterene—Dermatitis—Estramustine—prostate cancer	0.00145	0.00552	CcSEcCtD
Triamterene—Thrombocytopenia—Bicalutamide—prostate cancer	0.00144	0.0055	CcSEcCtD
Triamterene—Headache—Estramustine—prostate cancer	0.00144	0.00549	CcSEcCtD
Triamterene—Vomiting—Abiraterone—prostate cancer	0.00142	0.00541	CcSEcCtD
Triamterene—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00141	0.00539	CcSEcCtD
Triamterene—Rash—Abiraterone—prostate cancer	0.00141	0.00537	CcSEcCtD
Triamterene—Dermatitis—Abiraterone—prostate cancer	0.00141	0.00536	CcSEcCtD
Triamterene—Hypokalaemia—Mitoxantrone—prostate cancer	0.0014	0.00534	CcSEcCtD
Triamterene—Vomiting—Estrone—prostate cancer	0.0014	0.00533	CcSEcCtD
Triamterene—Diarrhoea—Nilutamide—prostate cancer	0.0014	0.00532	CcSEcCtD
Triamterene—Diarrhoea—Flutamide—prostate cancer	0.00139	0.0053	CcSEcCtD
Triamterene—Rash—Estrone—prostate cancer	0.00139	0.00528	CcSEcCtD
Triamterene—Dermatitis—Estrone—prostate cancer	0.00139	0.00528	CcSEcCtD
Triamterene—Headache—Estrone—prostate cancer	0.00138	0.00525	CcSEcCtD
Triamterene—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00138	0.00524	CcSEcCtD
Triamterene—Nausea—Estramustine—prostate cancer	0.00137	0.00521	CcSEcCtD
Triamterene—Dizziness—Nilutamide—prostate cancer	0.00135	0.00514	CcSEcCtD
Triamterene—Dizziness—Flutamide—prostate cancer	0.00134	0.00512	CcSEcCtD
Triamterene—Hypersensitivity—Degarelix—prostate cancer	0.00134	0.00512	CcSEcCtD
Triamterene—Asthenia—Degarelix—prostate cancer	0.00131	0.00499	CcSEcCtD
Triamterene—Nausea—Estrone—prostate cancer	0.00131	0.00497	CcSEcCtD
Triamterene—Photosensitivity reaction—Estradiol—prostate cancer	0.00131	0.00497	CcSEcCtD
Triamterene—Vomiting—Nilutamide—prostate cancer	0.0013	0.00495	CcSEcCtD
Triamterene—Vomiting—Flutamide—prostate cancer	0.00129	0.00492	CcSEcCtD
Triamterene—Rash—Nilutamide—prostate cancer	0.00129	0.0049	CcSEcCtD
Triamterene—Dermatitis—Nilutamide—prostate cancer	0.00129	0.0049	CcSEcCtD
Triamterene—Rash—Flutamide—prostate cancer	0.00128	0.00488	CcSEcCtD
Triamterene—Dermatitis—Flutamide—prostate cancer	0.00128	0.00488	CcSEcCtD
Triamterene—Headache—Nilutamide—prostate cancer	0.00128	0.00487	CcSEcCtD
Triamterene—Headache—Flutamide—prostate cancer	0.00127	0.00485	CcSEcCtD
Triamterene—Fatigue—Bicalutamide—prostate cancer	0.00127	0.00484	CcSEcCtD
Triamterene—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00127	0.00483	CcSEcCtD
Triamterene—Hypersensitivity—Cabazitaxel—prostate cancer	0.00127	0.00482	CcSEcCtD
Triamterene—Diarrhoea—Degarelix—prostate cancer	0.00125	0.00475	CcSEcCtD
Triamterene—Jaundice—Estradiol—prostate cancer	0.00124	0.00473	CcSEcCtD
Triamterene—Asthenia—Cabazitaxel—prostate cancer	0.00123	0.0047	CcSEcCtD
Triamterene—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00122	0.00465	CcSEcCtD
Triamterene—Nausea—Nilutamide—prostate cancer	0.00121	0.00462	CcSEcCtD
Triamterene—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00121	0.00461	CcSEcCtD
Triamterene—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00121	0.0046	CcSEcCtD
Triamterene—Nausea—Flutamide—prostate cancer	0.00121	0.0046	CcSEcCtD
Triamterene—Dizziness—Degarelix—prostate cancer	0.00121	0.0046	CcSEcCtD
Triamterene—Headache—Estradiol valerate/Dienogest—prostate cancer	0.0012	0.00458	CcSEcCtD
Triamterene—Diarrhoea—Cabazitaxel—prostate cancer	0.00118	0.00448	CcSEcCtD
Triamterene—Photosensitivity—Capecitabine—prostate cancer	0.00118	0.00448	CcSEcCtD
Triamterene—Vomiting—Degarelix—prostate cancer	0.00116	0.00442	CcSEcCtD
Triamterene—Jaundice—Mitoxantrone—prostate cancer	0.00116	0.00441	CcSEcCtD
Triamterene—Rash—Degarelix—prostate cancer	0.00115	0.00438	CcSEcCtD
Triamterene—Dermatitis—Degarelix—prostate cancer	0.00115	0.00438	CcSEcCtD
Triamterene—Headache—Degarelix—prostate cancer	0.00114	0.00435	CcSEcCtD
Triamterene—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00114	0.00434	CcSEcCtD
Triamterene—Dizziness—Cabazitaxel—prostate cancer	0.00114	0.00433	CcSEcCtD
Triamterene—Renal failure acute—Capecitabine—prostate cancer	0.00112	0.00426	CcSEcCtD
Triamterene—Vomiting—Cabazitaxel—prostate cancer	0.00109	0.00416	CcSEcCtD
Triamterene—Hypersensitivity—Bicalutamide—prostate cancer	0.00109	0.00414	CcSEcCtD
Triamterene—Nausea—Degarelix—prostate cancer	0.00108	0.00413	CcSEcCtD
Triamterene—Headache—Cabazitaxel—prostate cancer	0.00108	0.0041	CcSEcCtD
Triamterene—Fatigue—Ethinyl Estradiol—prostate cancer	0.00107	0.00409	CcSEcCtD
Triamterene—Asthenia—Bicalutamide—prostate cancer	0.00106	0.00403	CcSEcCtD
Triamterene—Dry mouth—Goserelin—prostate cancer	0.00105	0.00399	CcSEcCtD
Triamterene—Anaphylactic shock—Goserelin—prostate cancer	0.00103	0.00391	CcSEcCtD
Triamterene—Nausea—Cabazitaxel—prostate cancer	0.00102	0.00389	CcSEcCtD
Triamterene—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00102	0.00387	CcSEcCtD
Triamterene—Diarrhoea—Bicalutamide—prostate cancer	0.00101	0.00384	CcSEcCtD
Triamterene—Thrombocytopenia—Goserelin—prostate cancer	0.001	0.00382	CcSEcCtD
Triamterene—Dizziness—Bicalutamide—prostate cancer	0.000975	0.00371	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—prostate cancer	0.000973	0.00371	CcSEcCtD
Triamterene—Jaundice—Etoposide—prostate cancer	0.000963	0.00367	CcSEcCtD
Triamterene—Hypokalaemia—Capecitabine—prostate cancer	0.000939	0.00358	CcSEcCtD
Triamterene—Vomiting—Bicalutamide—prostate cancer	0.000938	0.00357	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—prostate cancer	0.000935	0.00356	CcSEcCtD
Triamterene—Rash—Bicalutamide—prostate cancer	0.00093	0.00354	CcSEcCtD
Triamterene—Dermatitis—Bicalutamide—prostate cancer	0.000929	0.00354	CcSEcCtD
Triamterene—Headache—Bicalutamide—prostate cancer	0.000924	0.00352	CcSEcCtD
Triamterene—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000918	0.0035	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—prostate cancer	0.0009	0.00343	CcSEcCtD
Triamterene—Asthenia—Ethinyl Estradiol—prostate cancer	0.000894	0.00341	CcSEcCtD
Triamterene—Fatigue—Goserelin—prostate cancer	0.000884	0.00337	CcSEcCtD
Triamterene—Fatigue—Conjugated Estrogens—prostate cancer	0.000876	0.00334	CcSEcCtD
Triamterene—Nausea—Bicalutamide—prostate cancer	0.000876	0.00334	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—prostate cancer	0.000865	0.00329	CcSEcCtD
Triamterene—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000853	0.00325	CcSEcCtD
Triamterene—Hypokalaemia—Prednisone—prostate cancer	0.000836	0.00319	CcSEcCtD
Triamterene—Dry mouth—Estradiol—prostate cancer	0.00083	0.00316	CcSEcCtD
Triamterene—Dizziness—Ethinyl Estradiol—prostate cancer	0.000824	0.00314	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—prostate cancer	0.000819	0.00312	CcSEcCtD
Triamterene—Photosensitivity reaction—Capecitabine—prostate cancer	0.000814	0.0031	CcSEcCtD
Triamterene—Anaphylactic shock—Estradiol—prostate cancer	0.000813	0.0031	CcSEcCtD
Triamterene—Jaundice—Docetaxel—prostate cancer	0.000801	0.00305	CcSEcCtD
Triamterene—Vomiting—Ethinyl Estradiol—prostate cancer	0.000793	0.00302	CcSEcCtD
Triamterene—Rash—Ethinyl Estradiol—prostate cancer	0.000786	0.00299	CcSEcCtD
Triamterene—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000785	0.00299	CcSEcCtD
Triamterene—Headache—Ethinyl Estradiol—prostate cancer	0.000781	0.00297	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—prostate cancer	0.000779	0.00297	CcSEcCtD
Triamterene—Jaundice—Capecitabine—prostate cancer	0.000775	0.00295	CcSEcCtD
Triamterene—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000758	0.00289	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—prostate cancer	0.000757	0.00288	CcSEcCtD
Triamterene—Hypersensitivity—Goserelin—prostate cancer	0.000756	0.00288	CcSEcCtD
Triamterene—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000749	0.00285	CcSEcCtD
Triamterene—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000742	0.00283	CcSEcCtD
Triamterene—Nausea—Ethinyl Estradiol—prostate cancer	0.00074	0.00282	CcSEcCtD
Triamterene—Asthenia—Goserelin—prostate cancer	0.000736	0.0028	CcSEcCtD
Triamterene—Asthenia—Conjugated Estrogens—prostate cancer	0.000729	0.00278	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—prostate cancer	0.00072	0.00274	CcSEcCtD
Triamterene—Diarrhoea—Goserelin—prostate cancer	0.000702	0.00267	CcSEcCtD
Triamterene—Fatigue—Estradiol—prostate cancer	0.000701	0.00267	CcSEcCtD
Triamterene—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000695	0.00265	CcSEcCtD
Triamterene—Dizziness—Goserelin—prostate cancer	0.000678	0.00258	CcSEcCtD
Triamterene—Dizziness—Conjugated Estrogens—prostate cancer	0.000672	0.00256	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—prostate cancer	0.000654	0.00249	CcSEcCtD
Triamterene—Fatigue—Mitoxantrone—prostate cancer	0.000653	0.00249	CcSEcCtD
Triamterene—Vomiting—Goserelin—prostate cancer	0.000652	0.00248	CcSEcCtD
Triamterene—Rash—Goserelin—prostate cancer	0.000647	0.00246	CcSEcCtD
Triamterene—Dermatitis—Goserelin—prostate cancer	0.000646	0.00246	CcSEcCtD
Triamterene—Vomiting—Conjugated Estrogens—prostate cancer	0.000646	0.00246	CcSEcCtD
Triamterene—Headache—Goserelin—prostate cancer	0.000643	0.00245	CcSEcCtD
Triamterene—Rash—Conjugated Estrogens—prostate cancer	0.000641	0.00244	CcSEcCtD
Triamterene—Dermatitis—Conjugated Estrogens—prostate cancer	0.00064	0.00244	CcSEcCtD
Triamterene—Headache—Conjugated Estrogens—prostate cancer	0.000637	0.00242	CcSEcCtD
Triamterene—Anaphylactic shock—Etoposide—prostate cancer	0.00063	0.0024	CcSEcCtD
Triamterene—Thrombocytopenia—Etoposide—prostate cancer	0.000617	0.00235	CcSEcCtD
Triamterene—Nausea—Goserelin—prostate cancer	0.000609	0.00232	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—prostate cancer	0.000605	0.00231	CcSEcCtD
Triamterene—Nausea—Conjugated Estrogens—prostate cancer	0.000604	0.0023	CcSEcCtD
Triamterene—Hypersensitivity—Estradiol—prostate cancer	0.000599	0.00228	CcSEcCtD
Triamterene—Asthenia—Estradiol—prostate cancer	0.000583	0.00222	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—prostate cancer	0.000567	0.00216	CcSEcCtD
Triamterene—Hypersensitivity—Mitoxantrone—prostate cancer	0.000558	0.00213	CcSEcCtD
Triamterene—Diarrhoea—Estradiol—prostate cancer	0.000556	0.00212	CcSEcCtD
Triamterene—Asthenia—Mitoxantrone—prostate cancer	0.000544	0.00207	CcSEcCtD
Triamterene—Fatigue—Etoposide—prostate cancer	0.000543	0.00207	CcSEcCtD
Triamterene—Jaundice—Epirubicin—prostate cancer	0.00054	0.00206	CcSEcCtD
Triamterene—Dizziness—Estradiol—prostate cancer	0.000538	0.00205	CcSEcCtD
Triamterene—Dry mouth—Docetaxel—prostate cancer	0.000534	0.00204	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000525	0.002	CcSEcCtD
Triamterene—Anaphylactic shock—Docetaxel—prostate cancer	0.000524	0.00199	CcSEcCtD
Triamterene—Diarrhoea—Mitoxantrone—prostate cancer	0.000518	0.00197	CcSEcCtD
Triamterene—Dry mouth—Capecitabine—prostate cancer	0.000517	0.00197	CcSEcCtD
Triamterene—Vomiting—Estradiol—prostate cancer	0.000517	0.00197	CcSEcCtD
Triamterene—Thrombocytopenia—Docetaxel—prostate cancer	0.000513	0.00195	CcSEcCtD
Triamterene—Rash—Estradiol—prostate cancer	0.000513	0.00195	CcSEcCtD
Triamterene—Dermatitis—Estradiol—prostate cancer	0.000512	0.00195	CcSEcCtD
Triamterene—Headache—Estradiol—prostate cancer	0.000509	0.00194	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—prostate cancer	0.0005	0.0019	CcSEcCtD
Triamterene—Thrombocytopenia—Capecitabine—prostate cancer	0.000497	0.00189	CcSEcCtD
Triamterene—Nausea—Estradiol—prostate cancer	0.000483	0.00184	CcSEcCtD
Triamterene—Vomiting—Mitoxantrone—prostate cancer	0.000482	0.00183	CcSEcCtD
Triamterene—Rash—Mitoxantrone—prostate cancer	0.000478	0.00182	CcSEcCtD
Triamterene—Dermatitis—Mitoxantrone—prostate cancer	0.000477	0.00182	CcSEcCtD
Triamterene—Headache—Mitoxantrone—prostate cancer	0.000475	0.00181	CcSEcCtD
Triamterene—Hypersensitivity—Etoposide—prostate cancer	0.000464	0.00177	CcSEcCtD
Triamterene—Asthenia—Etoposide—prostate cancer	0.000452	0.00172	CcSEcCtD
Triamterene—Anaphylactic shock—Prednisone—prostate cancer	0.000452	0.00172	CcSEcCtD
Triamterene—Fatigue—Docetaxel—prostate cancer	0.000452	0.00172	CcSEcCtD
Triamterene—Nausea—Mitoxantrone—prostate cancer	0.00045	0.00171	CcSEcCtD
Triamterene—Fatigue—Capecitabine—prostate cancer	0.000437	0.00167	CcSEcCtD
Triamterene—Diarrhoea—Etoposide—prostate cancer	0.000431	0.00164	CcSEcCtD
Triamterene—Dizziness—Etoposide—prostate cancer	0.000417	0.00159	CcSEcCtD
Triamterene—Vomiting—Etoposide—prostate cancer	0.000401	0.00153	CcSEcCtD
Triamterene—Rash—Etoposide—prostate cancer	0.000397	0.00151	CcSEcCtD
Triamterene—Dermatitis—Etoposide—prostate cancer	0.000397	0.00151	CcSEcCtD
Triamterene—Headache—Etoposide—prostate cancer	0.000395	0.0015	CcSEcCtD
Triamterene—Fatigue—Prednisone—prostate cancer	0.000389	0.00148	CcSEcCtD
Triamterene—Hypersensitivity—Docetaxel—prostate cancer	0.000386	0.00147	CcSEcCtD
Triamterene—Asthenia—Docetaxel—prostate cancer	0.000376	0.00143	CcSEcCtD
Triamterene—Nausea—Etoposide—prostate cancer	0.000374	0.00143	CcSEcCtD
Triamterene—Hypersensitivity—Capecitabine—prostate cancer	0.000374	0.00142	CcSEcCtD
Triamterene—Asthenia—Capecitabine—prostate cancer	0.000364	0.00139	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—prostate cancer	0.00036	0.00137	CcSEcCtD
Triamterene—Diarrhoea—Docetaxel—prostate cancer	0.000358	0.00136	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—prostate cancer	0.000353	0.00135	CcSEcCtD
Triamterene—Diarrhoea—Capecitabine—prostate cancer	0.000347	0.00132	CcSEcCtD
Triamterene—Dizziness—Docetaxel—prostate cancer	0.000346	0.00132	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—prostate cancer	0.000346	0.00132	CcSEcCtD
Triamterene—Dizziness—Capecitabine—prostate cancer	0.000335	0.00128	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—prostate cancer	0.000334	0.00127	CcSEcCtD
Triamterene—Vomiting—Docetaxel—prostate cancer	0.000333	0.00127	CcSEcCtD
Triamterene—Hypersensitivity—Prednisone—prostate cancer	0.000333	0.00127	CcSEcCtD
Triamterene—Rash—Docetaxel—prostate cancer	0.00033	0.00126	CcSEcCtD
Triamterene—Dermatitis—Docetaxel—prostate cancer	0.00033	0.00126	CcSEcCtD
Triamterene—Headache—Docetaxel—prostate cancer	0.000328	0.00125	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—prostate cancer	0.000327	0.00124	CcSEcCtD
Triamterene—Asthenia—Prednisone—prostate cancer	0.000324	0.00123	CcSEcCtD
Triamterene—Vomiting—Capecitabine—prostate cancer	0.000322	0.00123	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—prostate cancer	0.00032	0.00122	CcSEcCtD
Triamterene—Rash—Capecitabine—prostate cancer	0.00032	0.00122	CcSEcCtD
Triamterene—Dermatitis—Capecitabine—prostate cancer	0.000319	0.00122	CcSEcCtD
Triamterene—Headache—Capecitabine—prostate cancer	0.000318	0.00121	CcSEcCtD
Triamterene—Nausea—Docetaxel—prostate cancer	0.000311	0.00118	CcSEcCtD
Triamterene—Diarrhoea—Prednisone—prostate cancer	0.000309	0.00118	CcSEcCtD
Triamterene—Fatigue—Epirubicin—prostate cancer	0.000305	0.00116	CcSEcCtD
Triamterene—Nausea—Capecitabine—prostate cancer	0.000301	0.00115	CcSEcCtD
Triamterene—Dizziness—Prednisone—prostate cancer	0.000299	0.00114	CcSEcCtD
Triamterene—Vomiting—Prednisone—prostate cancer	0.000287	0.00109	CcSEcCtD
Triamterene—Rash—Prednisone—prostate cancer	0.000285	0.00108	CcSEcCtD
Triamterene—Dermatitis—Prednisone—prostate cancer	0.000285	0.00108	CcSEcCtD
Triamterene—Headache—Prednisone—prostate cancer	0.000283	0.00108	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—prostate cancer	0.000282	0.00107	CcSEcCtD
Triamterene—Nausea—Prednisone—prostate cancer	0.000268	0.00102	CcSEcCtD
Triamterene—Hypersensitivity—Epirubicin—prostate cancer	0.00026	0.000991	CcSEcCtD
Triamterene—Asthenia—Epirubicin—prostate cancer	0.000253	0.000965	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—prostate cancer	0.000242	0.000921	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—prostate cancer	0.000241	0.000917	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—prostate cancer	0.000235	0.000893	CcSEcCtD
Triamterene—Dizziness—Epirubicin—prostate cancer	0.000234	0.00089	CcSEcCtD
Triamterene—Vomiting—Epirubicin—prostate cancer	0.000225	0.000855	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—prostate cancer	0.000224	0.000852	CcSEcCtD
Triamterene—Rash—Epirubicin—prostate cancer	0.000223	0.000848	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—prostate cancer	0.000223	0.000848	CcSEcCtD
Triamterene—Headache—Epirubicin—prostate cancer	0.000221	0.000843	CcSEcCtD
Triamterene—Dizziness—Doxorubicin—prostate cancer	0.000216	0.000823	CcSEcCtD
Triamterene—Nausea—Epirubicin—prostate cancer	0.00021	0.000799	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—prostate cancer	0.000208	0.000792	CcSEcCtD
Triamterene—Rash—Doxorubicin—prostate cancer	0.000206	0.000785	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—prostate cancer	0.000206	0.000784	CcSEcCtD
Triamterene—Headache—Doxorubicin—prostate cancer	0.000205	0.00078	CcSEcCtD
Triamterene—Nausea—Doxorubicin—prostate cancer	0.000194	0.000739	CcSEcCtD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000188	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000187	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP7B1—prostate cancer	0.000185	0.00133	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000185	0.00133	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP7B1—prostate cancer	0.000183	0.00132	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—LPL—prostate cancer	0.000182	0.00131	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT1E1—prostate cancer	0.000181	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—prostate cancer	0.000181	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.000181	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.000179	0.00129	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—HPGDS—prostate cancer	0.000179	0.00128	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT1E1—prostate cancer	0.000178	0.00128	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000176	0.00127	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—prostate cancer	0.000176	0.00126	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—prostate cancer	0.000176	0.00126	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP1A1—prostate cancer	0.000176	0.00126	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000174	0.00125	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—prostate cancer	0.000173	0.00125	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000172	0.00124	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.00017	0.00122	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—CYP1A1—prostate cancer	0.000164	0.00118	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.00016	0.00115	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP3A5—prostate cancer	0.000159	0.00114	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP3A5—prostate cancer	0.000157	0.00113	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000155	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA3—prostate cancer	0.000154	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000152	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTA3—prostate cancer	0.000152	0.00109	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—prostate cancer	0.000146	0.00105	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000145	0.00104	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000143	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000142	0.00102	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA4—prostate cancer	0.000141	0.00101	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—TBXAS1—prostate cancer	0.000141	0.00101	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.00014	0.00101	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTA4—prostate cancer	0.000139	0.000997	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000138	0.000992	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA2—prostate cancer	0.000137	0.000985	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT1A1—prostate cancer	0.000135	0.000973	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GGT1—prostate cancer	0.000134	0.000962	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT1A1—prostate cancer	0.000133	0.00096	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA1—prostate cancer	0.000132	0.000951	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTO1—prostate cancer	0.000131	0.00094	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NAT2—prostate cancer	0.000131	0.00094	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—NAT2—prostate cancer	0.000129	0.000927	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTO1—prostate cancer	0.000129	0.000927	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2C18—prostate cancer	0.000125	0.000901	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2C18—prostate cancer	0.000124	0.000889	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—prostate cancer	0.000122	0.000876	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—COMT—prostate cancer	0.000121	0.000868	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—prostate cancer	0.00012	0.000864	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—SULT2A1—prostate cancer	0.000116	0.000838	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000115	0.000829	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—SULT2A1—prostate cancer	0.000115	0.000826	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.000111	0.000795	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000111	0.000795	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—prostate cancer	0.00011	0.000794	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GPX3—prostate cancer	0.00011	0.000788	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MDM2—prostate cancer	0.000108	0.00078	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—prostate cancer	0.000105	0.000752	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—HPGDS—prostate cancer	0.000104	0.000752	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2C19—prostate cancer	0.000104	0.000747	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2C19—prostate cancer	0.000102	0.000737	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—prostate cancer	0.000101	0.000729	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2A6—prostate cancer	0.0001	0.000721	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—prostate cancer	9.9e-05	0.000712	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—prostate cancer	9.9e-05	0.000712	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—prostate cancer	9.78e-05	0.000703	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—prostate cancer	9.69e-05	0.000697	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	9.66e-05	0.000695	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—AKR1C3—prostate cancer	9.61e-05	0.000691	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP17A1—prostate cancer	9.59e-05	0.00069	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP17A1—prostate cancer	9.46e-05	0.000681	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	9.16e-05	0.000659	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	9.16e-05	0.000659	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	9.16e-05	0.000659	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NCOA2—prostate cancer	9.14e-05	0.000658	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—prostate cancer	9.14e-05	0.000657	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	8.74e-05	0.000629	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—prostate cancer	8.69e-05	0.000625	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—prostate cancer	8.69e-05	0.000625	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2E1—prostate cancer	8.52e-05	0.000613	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—prostate cancer	8.45e-05	0.000608	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—prostate cancer	8.45e-05	0.000608	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2E1—prostate cancer	8.4e-05	0.000604	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—prostate cancer	8.23e-05	0.000592	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP3A4—prostate cancer	8.21e-05	0.000591	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP3A4—prostate cancer	8.1e-05	0.000583	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1B1—prostate cancer	8.07e-05	0.000581	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1B1—prostate cancer	7.96e-05	0.000573	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GGT1—prostate cancer	7.82e-05	0.000563	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	7.79e-05	0.00056	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—NCOA1—prostate cancer	7.7e-05	0.000554	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP19A1—prostate cancer	7.59e-05	0.000546	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—prostate cancer	7.57e-05	0.000545	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—prostate cancer	7.56e-05	0.000544	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP19A1—prostate cancer	7.49e-05	0.000539	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—prostate cancer	7.41e-05	0.000533	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—prostate cancer	7.41e-05	0.000533	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—RXRA—prostate cancer	7.33e-05	0.000527	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	7.32e-05	0.000527	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	7.12e-05	0.000512	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—COMT—prostate cancer	7.06e-05	0.000508	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—prostate cancer	7.02e-05	0.000505	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—prostate cancer	7e-05	0.000503	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—COMT—prostate cancer	6.96e-05	0.000501	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	6.94e-05	0.000499	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—prostate cancer	6.93e-05	0.000498	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	6.62e-05	0.000476	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	6.62e-05	0.000476	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—prostate cancer	6.45e-05	0.000464	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—prostate cancer	6.37e-05	0.000458	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP1A1—prostate cancer	6.12e-05	0.00044	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HAO1—prostate cancer	6.04e-05	0.000434	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	6.03e-05	0.000434	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	5.63e-05	0.000405	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	5.4e-05	0.000388	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	5.2e-05	0.000374	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	5.02e-05	0.000361	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PSAT1—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CSAD—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TST—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GRHL1—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADI1—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CBR1—prostate cancer	4.92e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.81e-05	0.000346	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.72e-05	0.000339	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UGT2B17—prostate cancer	4.58e-05	0.000329	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UGT2B15—prostate cancer	4.58e-05	0.000329	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GRHPR—prostate cancer	4.58e-05	0.000329	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CKMT2—prostate cancer	4.58e-05	0.000329	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.47e-05	0.000322	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.4e-05	0.000317	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—RFK—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM3—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAGLU—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT2B1—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MBTPS1—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AOX1—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PGAM2—prostate cancer	4.3e-05	0.00031	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	4.21e-05	0.000303	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP3A43—prostate cancer	4.08e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AMACR—prostate cancer	4.08e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DEGS1—prostate cancer	4.08e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAT1—prostate cancer	4.08e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SRD5A2—prostate cancer	4.08e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	4.01e-05	0.000289	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.99e-05	0.000287	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD17B1—prostate cancer	3.89e-05	0.00028	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.89e-05	0.00028	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.74e-05	0.000269	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.72e-05	0.000268	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.68e-05	0.000265	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.51e-05	0.000252	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—B4GALT4—prostate cancer	3.47e-05	0.000249	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HPGD—prostate cancer	3.47e-05	0.000249	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TNFRSF21—prostate cancer	3.26e-05	0.000235	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP7B1—prostate cancer	3.17e-05	0.000228	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTAP—prostate cancer	3.17e-05	0.000228	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	3.1e-05	0.000223	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SRD5A1—prostate cancer	3.09e-05	0.000222	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT1E1—prostate cancer	3.09e-05	0.000222	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	3e-05	0.000216	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.96e-05	0.000213	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD17B3—prostate cancer	2.95e-05	0.000212	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACSL4—prostate cancer	2.95e-05	0.000212	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.91e-05	0.00021	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PHGDH—prostate cancer	2.83e-05	0.000203	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UMPS—prostate cancer	2.83e-05	0.000203	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ARG2—prostate cancer	2.83e-05	0.000203	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.81e-05	0.000202	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDHB—prostate cancer	2.77e-05	0.000199	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP3A5—prostate cancer	2.72e-05	0.000196	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UCP3—prostate cancer	2.63e-05	0.000189	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA3—prostate cancer	2.63e-05	0.000189	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TCN2—prostate cancer	2.63e-05	0.000189	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PDHA1—prostate cancer	2.63e-05	0.000189	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC22A3—prostate cancer	2.51e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD3B1—prostate cancer	2.51e-05	0.00018	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.43e-05	0.000175	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TBXAS1—prostate cancer	2.4e-05	0.000173	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA4—prostate cancer	2.4e-05	0.000173	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.35e-05	0.000169	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA2—prostate cancer	2.34e-05	0.000169	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT1A1—prostate cancer	2.31e-05	0.000166	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG5—prostate cancer	2.31e-05	0.000166	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA1—prostate cancer	2.26e-05	0.000163	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSD3B2—prostate cancer	2.23e-05	0.000161	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTO1—prostate cancer	2.23e-05	0.000161	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAT2—prostate cancer	2.23e-05	0.000161	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.15e-05	0.000155	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LRP2—prostate cancer	2.14e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLCB2—prostate cancer	2.14e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2C18—prostate cancer	2.14e-05	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—P4HB—prostate cancer	2.1e-05	0.000151	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC22A1—prostate cancer	2.04e-05	0.000147	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.02e-05	0.000145	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SULT2A1—prostate cancer	1.99e-05	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MED12—prostate cancer	1.96e-05	0.000141	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GNG5—prostate cancer	1.94e-05	0.00014	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA3—prostate cancer	1.87e-05	0.000135	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.84e-05	0.000132	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HPGDS—prostate cancer	1.79e-05	0.000129	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2C19—prostate cancer	1.78e-05	0.000128	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACHE—prostate cancer	1.73e-05	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—prostate cancer	1.73e-05	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2A6—prostate cancer	1.71e-05	0.000123	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.71e-05	0.000123	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKR1C3—prostate cancer	1.67e-05	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PRKACB—prostate cancer	1.66e-05	0.000119	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.64e-05	0.000118	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.62e-05	0.000116	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA2—prostate cancer	1.56e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.49e-05	0.000107	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.46e-05	0.000105	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NQO1—prostate cancer	1.44e-05	0.000104	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TH—prostate cancer	1.42e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.41e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.4e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.4e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.38e-05	9.93e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GGT1—prostate cancer	1.34e-05	9.62e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA1—prostate cancer	1.32e-05	9.48e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.3e-05	9.34e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—RXRA—prostate cancer	1.25e-05	9.01e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.22e-05	8.77e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COMT—prostate cancer	1.21e-05	8.68e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—prostate cancer	1.2e-05	8.64e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ITPR1—prostate cancer	1.18e-05	8.5e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.16e-05	8.36e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TYMS—prostate cancer	1.12e-05	8.03e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—prostate cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPL—prostate cancer	1.08e-05	7.79e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.05e-05	7.53e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ERCC2—prostate cancer	1.04e-05	7.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—prostate cancer	9.76e-06	7.02e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARA—prostate cancer	9.57e-06	6.88e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAV1—prostate cancer	9e-06	6.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.6e-06	6.18e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—prostate cancer	8.2e-06	5.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—INS—prostate cancer	7.76e-06	5.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CREBBP—prostate cancer	7.6e-06	5.47e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CD—prostate cancer	7.21e-06	5.18e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—prostate cancer	6.8e-06	4.89e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CB—prostate cancer	6.28e-06	4.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—prostate cancer	6.22e-06	4.48e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTEN—prostate cancer	5.43e-06	3.9e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—EP300—prostate cancer	5.18e-06	3.72e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.83e-06	2.75e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—prostate cancer	3.13e-06	2.25e-05	CbGpPWpGaD
